Company Filing History:
4 out of 222 
2 out of 140 
1 out of 3 Years Active: 2010-2020
Title: Innovations of Takumi Teratani
Introduction
Takumi Teratani is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of genetically modified organisms. With a total of five patents to his name, Teratani's work has the potential to impact various areas of medical research and treatment.
Latest Patents
One of his latest patents involves a genetically modified rat derived from rat embryonic stem cells. This invention provides a rat embryonic stem cell characterized by several properties, including the expression of the Oct3/4 and Nanog genes, positive alkaline phosphatase activity, and the ability to form embryoid bodies. Additionally, these cells express Stage-Specific Embryonic Antigens (SSEA)-1 and SSEA-4, possess the same number of chromosomes as normal rat cells, and can be subcultured while maintaining an undifferentiated state. The cells also exhibit in vitro pluripotency, the potential to differentiate into cells of three embryonic germ lineages, teratoma formation ability, and the capability to produce a chimeric rat.
Career Highlights
Throughout his career, Takumi Teratani has worked with prestigious organizations, including the National Cancer Center and Dainippon Sumitomo Pharma Co., Ltd. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Takahiro Ochiya and Masanao Munekane. Their collaborative efforts have contributed to advancements in the field of biotechnology and stem cell research.
Conclusion
Takumi Teratani's innovative work in the realm of genetically modified organisms showcases his dedication to advancing scientific knowledge and medical applications. His contributions are likely to have lasting effects on the future of biotechnology and regenerative medicine.